Figure S1. Participant gut microbiome sampling across three doses of COVID-19 vaccinations (V1, vaccine dose 1; V2, vaccine dose 2; and V3, vaccine dose 3) from the different cohorts: healthy control, immune-checkpoint therapy-treated cancer patients, or patients with primary immunodeficiencies.